Salarius Pharmaceuticals, Inc.

Clinical-stage biopharma developing targeted protein therapies for cancer and viral diseases.

SLRX | NDAQ

Overview

Corporate Details

ISIN(s):: US79400X4043 (+1 more)
LEI:
Country:: United States of America
Address:: 2450 HOLCOMBE BLVD, 77021 HOUSTON
Website:: https://salariuspharma.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Salarius Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for patients with cancer and other diseases with high unmet medical needs. The company's technology aims to correct the dysregulated gene expression that drives disease progression. Its pipeline is built on two primary drug classes: targeted protein inhibitors (TPIs) and targeted protein degraders (TPDs). The lead TPI candidate, seclidemstat (SP-2577), is in Phase 1/2 clinical trials for solid and hematologic cancers like leukemias and lymphomas. The company's TPD candidate, SP-3164, is in IND-enabling studies. Following a merger with Decoy Therapeutics, Salarius is also advancing peptide therapeutics for cancer and respiratory viruses.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Salarius Pharmaceuticals, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Salarius Pharmaceuticals, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Salarius Pharmaceuticals, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
INVITES BIOCORE CO., LTD A CRO advancing precision medicine via genomic analysis and clinical trial support services.	South Korea	216400
IQVIA HOLDINGS INC. Global provider of analytics, tech, and clinical research for life sciences and healthcare.	United States of America	IQV
Isofol Medical Developing a drug to enhance chemotherapy efficacy for solid tumors like colorectal cancer.	Sweden	ISOFOL
ITOXI Corp. B2B platform for Ukraine-Korea trade, investment, and post-war reconstruction.	South Korea	052770
IVISIONWORKS CO.,LTD. Accelerates social impact startups & develops digital therapeutics for cognitive rehabilitation.	South Korea	469750
Jardine Matheson Hldgs Ltd A diversified, Asia-focused conglomerate with businesses in property, retail, auto, and more.	Bermuda	JARD
JSC National Atomic Co. Kazatomprom The world's largest uranium producer, managing the front-end of the global nuclear fuel cycle.	Kazakhstan	KZAP
KAINOS MEDICINE, INC. Develops small molecule drugs for neurodegenerative diseases, cancers, and infectious diseases.	South Korea	284620
Kanamoto Co., Ltd. Global provider of rental construction equipment, also selling used machinery and steel products.	Japan	9678
Keihan Holdings Co.,Ltd. A conglomerate integrating transport, real estate, and retail for regional development.	Japan	9045